Ep. 25: Alice Valder Curran on Drug Pricing under the Inflation Reduction Act
In this episode, VibeCast host Ray Dogum speaks with Alice Valder Curran, Partner at Hogan Lovells, about Novel Drug Pricing & How Consumers Impact Drug Pricing. Key moments: 00:00:00 - Introduction, 00:01:45 - No Patient Left Behind, 00:02:47 - Innovative Legal Practitioner, 00:06:19 - Challenges in Drug Pricing, 00:09:15 - Updating Pricing Policies, 00:16:28 - The Impact of the IRA on Drug Pricing, 00:17:22 - Challenges with the Orphan Drug Act, 00:19:35 - Impact on Biotech Companies, 00:21:37 - Start Thinking Early, 00:26:04 - Consumer-Driven Pricing, 00:32:45 - The Importance of the Biotechnology Industry, 00:34:00 - Advancements in Medical Therapies, 00:34:58 - Market Access and Lifecycle Management for Biotech Companies, 00:38:10 - The Role of Patient Communities Guest Bio: Alice Valder Curran is a regulatory expert, strategic business and legal advisor to multinational pharmaceutical and biotech companies. Leads commercialization, compliance, and policy matters at all stages of development. Special focus where significant public policy considerations are informed by regulatory sensitivities and strategic business priorities. Hyper-focused on innovation, collaboration, and sustainability. Converts evolving regulatory issues into opportunities, value, and competitive advantage. Designs cutting-edge regulatory pathways that bring new drug products to market -- maximizing client profits, facilitating patient access to critical therapies, and advancing important public policy objectives. Servant leader and entrepreneurial thinker. Executive leadership roles have included the firm’s International Management Committee, setting, and implementing the strategic direction and business operations for the global enterprise. Created the framework for the organization’s values and culture messaging rollout and embedment. Spearheaded and institutionalized firmwide resources and trainings on compensation, professional development, retention, and advancement. As the first leader of the organization’s newly combined Global Regulatory and Intellectual Property Practice, directed the integration of talent across Americas, EMEA, and APAC regions and sixteen legal disciplines, managed P&L, developed business development strategy, and delivered leading profitable and business growth results year-over-year. Passionate advocate and sponsor for women and diverse professionals. Drives DEI strategy and devotes energies to produce meaningful and industry-leading results in the advancement and retention of talent. Influential speaker. Inspires and motivates on leading-edge life sciences and biotech topics, as well as on leadership, business, empowerment and inclusion. Guest Links: Linkedin: https://www.linkedin.com/in/alicevaldercurran/ About VibeCast VibeCast is our weekly informational podcast and content series exploring the hottest topics in drug development and Web3 with some of the dynamic people that make up the Vibe community. VibeCast is a collection of long-form and short-form video content intended to help our community learn about the current opportunities and challenges in biotech fundraising and community engagement innovation. Follow Vibe Bio's Socials: https://twitter.com/VibeBio https://www.linkedin.com/company/vibe-bio/ https://www.instagram.com/vibebiotechnology/ https://www.tiktok.com/@vibebio https://www.facebook.com/VibeBiotechnology/ Disclaimer: VibeCast is intended to be used for educational and entertainment purposes, and no information or opinions shared constitute advice or services. While guests are invited to listen, listeners acknowledge they are not being provided professional advice from the podcast or the guests. The podcast is for private non-commercial use and the statements of our guests reflect their personal views only and do not necessarily reflect the views or positions of any agency, organization, or company that they work for or are affiliated with.
